Immunoglobulins of the IgA class are important in the specific immune defense of mucosal surfaces and perhaps in the regulation of secretory immunity. However, the mechanicsms involved in these activities are still incompletely understood. The recent demonstration that lymphocytes and effector cells populations display receptors for the Fc portion of IgA (RFc), suggests that these receptors may mediate interactions between IgA and/or IgA-antigen complexes and the effector or regulatory cell expressing RFc. The present proposal is directed toward an evaluation of the function of RFc and RFc - bearing human leukocyte subpopulations. We would first quantitate the expression of this receptor on various lymphocyte subpopulations and on leukocytes from peripheral blood and mucosal surfaces. Since the quantity of RFc per cell may be related to its functional activity, we would examine the ability of various mediators of immune function including supernatants from stimulated lymphocytes, immunoglobulins and immunoglobulin-antigen complexes to modulate expression of RFc on these cells. RFc would be isolated and partially characterized. Monoclonal antibodies to RFc would be prepared and used for further characterization of these receptors, and in studies of their function. The regulatory and effector properties of cells bearing RFc would be examined and the role of RFc in these functions would be determined. These studies would be performed on cells from peripheral and mucosal lymphoid tissues before and after modulation of RFc expression. In addition, myeloid cell-specific monoclonal antibodies would be used to isolate subpopulations of monocytes and PMNs for the subsequent analysis of the ability of these groups of cells to manifest RFc -dependent effector functions. The data obtained in these studies on RFc and RFc -bearing leukocyte subpopulations should enhance our understanding of the regulation and expression of secretory immunity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI019053-07
Application #
3128495
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1981-09-01
Project End
1988-08-31
Budget Start
1987-09-01
Budget End
1988-08-31
Support Year
7
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Guyre, C A; Keler, T; Swink, S L et al. (2001) Receptor modulation by Fc gamma RI-specific fusion proteins is dependent on receptor number and modified by IgG. J Immunol 167:6303-11
Wallace, P K; Tsang, K Y; Goldstein, J et al. (2001) Exogenous antigen targeted to FcgammaRI on myeloid cells is presented in association with MHC class I. J Immunol Methods 248:183-94
Guyre, C A; Barreda, M E; Swink, S L et al. (2001) Colocalization of Fc gamma RI-targeted antigen with class I MHC: implications for antigen processing. J Immunol 166:2469-78
Wallace, P K; Romet-Lemonne, J L; Chokri, M et al. (2000) Production of macrophage-activated killer cells for targeting of glioblastoma cells with bispecific antibody to FcgammaRI and the epidermal growth factor receptor. Cancer Immunol Immunother 49:493-503
Wallace, P K; Keler, T; Guyre, P M et al. (1997) Fc gamma RI blockade and modulation for immunotherapy. Cancer Immunol Immunother 45:137-41
Wallace, P K; Keler, T; Coleman, K et al. (1997) Humanized mAb H22 binds the human high affinity Fc receptor for IgG (FcgammaRI), blocks phagocytosis, and modulates receptor expression. J Leukoc Biol 62:469-79
Benoit, N E; Wade, W F (1996) Increased inhibition of proliferation of human B cell lymphomas following ligation of CD40, and either CD19, CD20, CD95 or surface immunoglobulin. Immunopharmacology 35:129-39
Ely, P; Wallace, P K; Givan, A L et al. (1996) Bispecific-armed, interferon gamma-primed macrophage-mediated phagocytosis of malignant non-Hodgkin's lymphoma. Blood 87:3813-21
Valone, F H; Kaufman, P A; Guyre, P M et al. (1995) Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu. J Clin Oncol 13:2281-92
Wallace, P K; Howell, A L; Fanger, M W (1994) Role of Fc gamma receptors in cancer and infectious disease. J Leukoc Biol 55:816-26

Showing the most recent 10 out of 45 publications